Biomedical research and corporate interests: A question of academic freedom

Mens Sana Monographs

Volumn 6, Issue 1, 2008, Pages 146-156

  McHenry, Leemon ^a  

^a CALIFORNIA STATE UNIVERSITY   (United States)

Author keywords

Academic freedom; Biomedical research; Critical rationalism; Ghostwriting; Key opinion leaders; Pharmaceutical funding; Pharmaceutical industry

Indexed keywords

EID: 44249120613     PISSN: 09731229     EISSN: 19984014     Source Type: Journal    
DOI: 10.4103/0973-1229.37086     Document Type: Article

References (32)

1. Angell M., (2004), The Truth About the Drug Companies: How They Deceive Us and What to Do About It. New York: Random House.
2. Angell M., (2006), Your Dangerous Drugstore, June 8, NY Rev Books, p38-40.
3. Baty P., (2005), Data Row Sparks Research Debate, THES, November 25, p39-40.
4. Berger V.W., (2002), Improving the Information Content of Categorical Clinical Trial End-points, Controlled Clinical Trials, 23, p502-514.
5. Berger V.W., Rezvani A., Makarewicz V.A., (2003), Direct Effect on Validity of Response Run-In Selection in Clinical Trials, Controlled Clinical Trails, 24, p156-166.
6. Chen A., Hróbjartsson A., Haahr M.T., Gøtzsche P.C., Altman D.G., (2007), Empirical Evidence for Selective Reporting of Outcomes in Randomized Trials, JAMA, 291, p2457-2465.
7. Dresser R., (2006), Pharmaceutical Company Gifts: From Voluntary Standards to Legal Demands, Hastings Cent Rep, 36, p8-9.
8. Elliott C., (2004), Pharma Goes to the Laundry: Public Relations and the Business of Medical Education, Hastings Cent Rep, 34, p19.
9. Fava G., (2002), Long-Term Treatment with Antidepressant Drugs: The Spectacular Achievements of Propaganda, Psychother Psychosom, 71, p127-132.
10. Fava G., (2004), Conflicts of Interest in Psychopharmacology: Can Dr. Jekyll Still Control Mr. Hyde? Psychother Psychosom, 73, p1-4.
11. Fava G., (2006), A Different Medicine is Possible, Psychother Psychosom, 75, p1-3.
12. Fugh-Berman A., (2005), The Corporate Coauthor, J. Gen Intl. Med, 20, p547.
13. Glassman P.A., Hunter-Hayes J., Nakamura T., (1999), Pharmaceutical Advertising Revenue and Physicians Organizations: How Much is too Much? Western J of Med, 171, p234-238.
14. Golden G.A., Parochka J.N., Overstreet K.M., (2002), Medical Education and Communication Companies: An Updated In-Depth Profile, J Contin Educ Health Prof, 22, p55-62.
15. Gottlieb S., (2006), Medical societies accused of being beholden to the drugs industry, BMJ, 319, p1321.
16. Healy D., (2004), Let Them Eat Prozac, New York: New York University Press.
17. Herman E., Chomski N., (1988), Manufacturing Consent: The Political Economy of the Mass Media. New York: Pantheon Books.
18. Horton R., (2004), The Dawn of McScience, NY Rev Books, March 11, p7-9.
19. Kesselheim A., Avorn J., (2007), The Role of Litigation in Defining Drug Risks, JAMA, 297, p308-11.
20. Krimsky S., (2006), Publication Bias, Data Ownership and the Funding Effect in Science: Threats to the Integrity of Biomedical Research. In: Rescuing Science from Politics: Regulation and Distortion of Scientific Research (Ed. by W. Wagner and R. Steinzor). Cambridge: Cambridge University Press, p61-85.
21. Lexchin J., Light D.W., (2006), Commercial Influence and the Content of Medical Journals, BMJ, 332, p1444-1447.
22. McHenry L., (2005), On the Origin of Great Ideas: Science in the Age of Big Pharma, Hastings Cent Rep, 35, p17-19.
23. Popper K., (1945), The Open Society and its Enemies, 2 vols. London: Routledge.
24. Popper K., (1961), The Poverty of Historicism. New York: Harper Torchbooks, p154-55.
25. Popper K., (1963), Conjectures and Refutations: The Growth of Scientific Knowledge. London: Routledge.
26. Schafer A., (2004), Biomedical Conflicts of Interest: a Defense of the Sequestration Thesis-Learning From the Cases of Nancy Olivieri and David Healy, J Med Ethics, 30, p8-24.
27. Singh A., Singh S., (2005), Medicine as a Corporate Enterprise, Patient Welfare Centered Profession or Patient Welfare Centered Professional Enterprise? Mens Sana Monographs, 3, p19-51.
28. Singh A., Singh S., (2007a), The Image of Pharma, Mens Sana Monographs, 5, p37-44.
29. Singh A., Singh S., (2007b), Clinical Practice Guidelines and Industry, Mens Sana Monographs, 5, p44-55.
30. Singh A., Singh S., (2007c), Academia, Journal Publishing and the Bio-Medical Industry, Mens Sana Monographs, 5, p11-14.
31. Smith R., (2005), Medical Journals Are an Extension of the Marketing Arm of Pharmaceutical Companies, Plos Med, 2, p e138.
32. Smith R., (2006), Lapses at the New England Journal of Medicine, J. Royal Society Med, 99, p1-3.